Evidence map›Paper›PMID 42256420›Full record

ArticleInnovations in pharmacy2025

Health technology in Nigeria: What are Nigerian startups working on?

Julia Oluwaseyi Tanimojo, Oladotun Erastus Okediji, Aishat Adenike Adebayo, Nora Ujunwa Ugwuanyi, Samad Olatunji Garuba, Sonsochukwu Godfrey Ezedigwe, Vivian Oluchukwu Anakudo

Abstract read
In one paragraph

Article in Innovations in pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julia Oluwaseyi TanimojoFaculty of Pharmacy, University of Lagos, Akoka, Nigeria.ORCID https://orcid.org/0009-0000-9899-1997
Oladotun Erastus OkedijiFaculty of Pharmaceutical Sciences, University of Ilorin, Nigeria.ORCID https://orcid.org/0009-0007-1517-0925
Aishat Adenike AdebayoCollege of Health Sciences, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria.ORCID https://orcid.org/0009-0001-2595-5191
Nora Ujunwa UgwuanyiFaculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria.ORCID https://orcid.org/0009-0003-0491-239X
Samad Olatunji GarubaDepartment of Surveying and Geoinformatics, University of Lagos, Akoka, Nigeria.ORCID https://orcid.org/0009-0000-4304-6912
Sonsochukwu Godfrey EzedigweUniversity College Hospital, University of Ibadan, Ibadan, Nigeria.ORCID https://orcid.org/0009-0005-5634-9708
Vivian Oluchukwu AnakudoAdvantage Health Africa, Lagos, Nigeria.ORCID https://orcid.org/0009-0001-8913-5918

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nigeria's healthcare system continues to face significant challenges, including limited access to quality care, insufficient infrastructure, and underfunded institutions. In response, health technology startups have emerged as innovative players, offering scalable, sustainable, and impactful solutions to address these systemic barriers. This commentary explores the diverse operational models-Business-to-Consumer (B2C), Business-to-Business (B2B), and Business-to-Government (B2G)-adopted by Nigerian health technology startups and evaluates their contributions to improving healthcare access, delivery, and efficiency. Through the use of telemedicine, digital diagnostics, electronic medical records, supply chain innovations, and mobile surveillance tools, these startups are filling critical gaps in the health system. However, the sector continues to grapple with regulatory uncertainty, infrastructure deficiencies, and data privacy concerns. By analyzing case studies such as Helium Health, LifeBank, Clafiya, and Wellvis, this paper highlights the current impact and future potential of digital health solutions in Nigeria. It concludes with strategic recommendations for policy reform, infrastructure investment, and stakeholder collaboration to support the sustainable growth of health technology in the country.

Indexed as

artificial intelligencebusiness-to-business modelbusiness-to-consumer modelsbusiness-to-government modelgovernment-to-consumer modelhealth tech in Nigeriahealth tech startups in Nigeriatelemedicine

Identifiers

PMID42256420
PMCPMC13233159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.